Koponen, Marjaana
Bell, J. Simon
Lalic, Samanta
Watson, Rosie
Koivisto, Anne M.
Ilomäki, Jenni
Article History
Received: 9 December 2021
Accepted: 19 April 2022
First Online: 3 June 2022
Declarations
:
: This research was conducted in accordance with the Declaration of Helsinki and the Australian Code for the Responsible Conduct of Research. The authors analysed non-identifiable data provided by Services Australia. No participants were contacted and informed consent was not required. The study was approved by the Monash University Human Research Ethics Committee (approval number 22877). The analysis plan was approved and the manuscript noted by the External Request Evaluation Committee chaired by Services Australia.
: Not applicable
: JSB and JI have received funding from Dementia Australia and Yulgilbar Foundation. JSB is funded by a National Health and Medical Research Council Boosting Dementia Leadership Fellowship and has received grant funding from National Health and Medical Research Council (NHMRC), Victorian Government Department of Health and Human Services (DHHS) and Dementia Australia Research Foundation (DARF), GlaxoSmithKline and several aged care provider organizations unrelated to this work. RW is supported by the Yulgilbar Alzheimer’s Research Program. AMK has received grant funding from HS Pitkänen Foundation and Päivikki and Sakari Sohlberg Foundation unrelated to this work. AMK has also received payments for lectures given to medical professionals from TEVA, Allergan, Nutricia, and Finnish Medical Society Duodecim and travel grants for medical congresses from the Finnish Neurological Association, TEVA, Roche, Allergan, and Biogen. JI has received grant funding from the NHMRC, Victorian Government DHHS, National Breast Cancer Foundation and DARF and consultancies from AstraZeneca unrelated to this work. SL and MK have nothing to disclose.